Normals (N = 42) and patients with mild memory
difficulty (N = 123) were given a neuropsychological
test battery, and then followed annually for 3 years to
determine which individuals developed sufficient functional
change that they met clinical criteria for AD. Twenty-three
of the 123 participants with mild memory difficulty converted
to a diagnosis of probable Alzheimer's disease (AD)
within 3 years of follow-up. Four of the 20 neuropsychological
measures obtained at baseline, were useful in discriminating
the groups on the basis of their status 3 years after the
tests were given. The 4 discriminating tests pertained
to assessments of memory and executive function. When the
controls were compared to the individuals with memory impairments
who ultimately developed AD (the converters),
the accuracy of discrimination was 89%, based on the neuropsychological
measures at baseline. The discrimination of the controls
from the individuals with mild memory problems who did
not progress to the point where they met clinical criteria
for probable AD over the 3 years of follow-up (the Questionables)
was 74% and the discrimination of the questionables from
the converters was 80%. The specific tests that contributed
to these discriminations, in conjunction with recent neuropathological
and neuroimaging data from preclinical cases, have implications
for which brain regions may be affected during the prodromal
phase of AD. (JINS, 2001, 7, 631–639.)
These findings are consistent with neuropathologic data showing substantial involvement of the entorhinal cortex in the preclinical phase of AD and suggest that, as the disease spreads, atrophic change develops within the hippocampus, which is measurable on MRI.
SPECT data gathered and analyzed in this manner may be useful as one aspect of the preclinical prediction of AD. Three of the four brain regions important for discriminating Converters from normal controls involve a distributed brain network pertaining to memory, suggesting that this network may be selectively affected in the earliest stages of AD.
Medical, neurodevelopmental, and parenting effects of individualized developmental care were investigated in a three-center, randomized, controlled trial. A total of 92 preterm infants, weighing less than 1250 g and aged less than 28 weeks, participated. Outcome measures included medical, neurodevelopmental and family function. Quality of care was also assessed. Multivariate analysis of variance investigated group, site, and interaction effects; correlation analysis identified individual variable contributions to significant effects. The results consistently favored the experimental groups. The following contributed to the group effects: shorter duration of parenteral feeding, transition to full oral feeding, intensive care, and hospitalization; lower incidence of necrotizing enterocolitis; reduced discharge ages and hospital charges; improved weight, length, and head circumferences; enhanced autonomic, motor, state, attention, and self-regulatory functioning; reduced need for facilitation; and lowered family stress and enhanced appreciation of the infant. Quality of care was measurably improved. Very low birth weight infants and their parents, across diverse settings, may benefit from individualized developmental care.
This is an application of new longitudinal structural equation modeling techniques to time-dependent associations of memory and brain structure measurements. There were 225 participants aged 30-80 years at baseline who were measured again after a 7-year interval on both the lateral ventricular size and Wechsler memory score. Multiple regression analyses show nonlinear associations with age but no relationships among longitudinal changes. Mixed-effects latent growth curve analyses and analyses based on latent difference scores indicate that longitudinal changes in both variables are reasonably well described by an exponential or dual change model. Bivariate dynamic structural equation modeling analyses indicate age-lagged changes operate in a coupled-over-time fashion, with the brain measure (lateral ventricular size) as a leading indicator in time of memory (Wechsler memory score) declines.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.